Paris (ots/PRNewswire) - - Worldwide invitation to create and submit concepts for a potential next-generation insulin delivery device - Sanofi announced today that it is accepting submissions for Ignite: The Diabetes Ideas Challenge ("Ignite ... weiter zur Pressemitteilung von Sanofi Diabetes
Paris (ots/PRNewswire) - - Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist - Sanofi announced today that the European Commission has granted Marketing Authorisation in Europe for Lyxumia(R) (lixisenatide). ... weiter zur Pressemitteilung von Sanofi Diabetes
| Presseportal: 3,86 Mio Visits im April Quelle: 
FEEDS
